- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04184726
Mindfulness Based Cognitive Therapy Modified for Visual Symptoms (MBCT-vision) (MBCT-vision)
Mindfulness Based Cognitive Therapy Modified for Visual Symptoms: MBCT-vision
This is a research study on Mindfulness-Based Cognitive Therapy for visual symptoms (MBCT-vision), to treat patients with debilitating symptoms of visual snow (VS) and is associated visual symptoms, severe light sensitivity (i.e. photophobia) and migrainous visual aura.
Participants will receive an intervention of an 8-week MBCT course modified for visual symptoms, which will involve 8 weeks of once weekly group sessions and home practice between sessions.
Study Overview
Status
Intervention / Treatment
Detailed Description
This is a research study on Mindfulness-Based Cognitive Therapy for visual symptoms (MBCT-vision), to treat patients with debilitating symptoms of visual snow (VS) and its associated visual symptoms, severe light sensitivity (i.e. photophobia) and migrainous visual aura.
VS is a condition of persistent flickering dots, like that of an out-of-focus analog television screen, affecting the whole visual field. There can be associated visual symptoms such as after-images, and trailing of images. No clinical trials for treatment have been done for VS. Instead, treatment data comes from patient case reports.
Photophobia describes discomfort or pain to light stimulation. Causes include eye surface issues, migraine, or of an unknown trigger, and can be persistent despite optimum management of underlying causes.
Patients with migrainous visual aura may have troublesome visual disturbances despite optimum migraine treatment.
Previous studies have shown that dysfunction in brain pathways contribute to the above conditions.
Mindfulness-Based Cognitive Therapy is a treatment that combines evidence-based approaches of Mindfulness-Based Stress Reduction and Cognitive Behavioural Therapy (CBT). MBCT is an established 8-week programme designed to develop skills of mindfulness and CBT strategies in individuals, through weekly small-group sessions and structured daily practice between sessions.
Studies on MBCT and mindfulness-based interventions have shown improvements in psychological resilience; physical health including immune function; and neural changes associated with psychological wellbeing.
The investigators propose that MBCT, modified to incorporate aspects relevant to persistent and distressing visual symptoms (MBCT-vision), can improve these debilitating symptoms by modifying dysfunctional neural pathways and equip patients with skills that promote psychological resilience and improve coping with residual symptoms.
For this study, the investigators will assess the use of MBCT-vision in patients with visual snow or associated visual symptoms, migrainous visual aura or photophobia. This will be the first study of a mindfulness-based intervention in this population.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom
- Guys & St Thomas' NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with visual snow or associated visual symptoms; photophobia for at least 3 months
- Patients with migrainous visual aura occurring >4 episodes a month for at least 3 months
Exclusion Criteria:
- Patient with a current severe depressive or psychotic episode
- Patient with severe difficulties in emotional regulation
- Patient unable to provide informed consent for participation
- Patient with insufficient understanding of spoken English (due to need to participate in group discussions)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MBCT-vision
8 x once weekly group sessions, and home practice between sessions
|
mindfulness and cognitive behavioural therapy techniques taught in group sessions meeting once weekly for 8 weeks, and home practice between sessions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in severity of visual symptoms
Time Frame: week 9 and 20
|
change in severity of visual symptoms pre- and post-intervention, comparing scores on Likert scale, ranging from 0/10 (no symptoms) to 10/10 (extremely severe symptoms)
|
week 9 and 20
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in World Health Organisation (WHO) wellbeing index scores
Time Frame: week 9 and 20
|
change in WHO wellbeing index, comparing pre- and post- intervention scores.
WHO wellbeing index range from 0-25, with higher scores representing increased wellbeing.
|
week 9 and 20
|
|
change in Clinical Outcomes in Routine Evaluation (CORE-10) scores
Time Frame: week 9 and 20
|
change in CORE-10 scores, comparing pre- and post- intervention.
CORE-10 scores range from 0-40 with higher scores indicating more distress.
|
week 9 and 20
|
|
change in Five-Facet Mindfulness Questionnaire (FFMQ) scores
Time Frame: week 9 and 20
|
change in Five-Facet Mindfulness Questionnaire scores, comparing pre- and post- intervention.
FFMQ scores range from 39-195 where higher scores represent more mindfulness
|
week 9 and 20
|
|
compliance (session attendance and completion of daily practice)
Time Frame: week 9
|
participant compliance from attendance record for MBCT-vision weekly sessions and self-report compliance with daily home practice
|
week 9
|
|
qualitative assessment of MBCT-vision
Time Frame: week 9
|
participant feedback on the design of MBCT-vision via structured qualitative interview
|
week 9
|
|
functional MRI
Time Frame: week 20
|
changes to functional MRI comparing baseline to week 20 - this has been added for participants recruited in the second and third cohort
|
week 20
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sui H Wong, MD, Guys & St Thomas'
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 266101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Visual Snow Syndrome
-
University of ZurichUSZ FoundationActive, not recruiting
-
University of ZurichBalgrist University HospitalRecruitingEpilepsy | Migraine | Visual Snow SyndromeSwitzerland
-
Guy's and St Thomas' NHS Foundation TrustNot yet recruitingVisual Snow Syndrome
-
University of Colorado, DenverCompletedVisual Snow SyndromeUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Fondation Ophtalmologique Adolphe de RothschildWithdrawnVisual Snow SyndromeFrance
-
University of MinnesotaMayo Clinic; National Eye Institute (NEI); National Institutes of Health (NIH)RecruitingHealthy | Migraine | Visual Snow SyndromeUnited States
-
Skolkovo Institute of Science and TechnologyI.M. Sechenov First Moscow State Medical UniversityRecruitingHealthy Volunteer | Visual Snow Syndrome | Color BlindnessRussian Federation
-
University of UlsterCompletedVisual Stress | Meares-Irlen Syndrome | Reading DifficultiesUnited Kingdom
-
Haukeland University HospitalUllevaal University HospitalCompletedAccident Caused by Snow AvalancheNorway
Clinical Trials on Mindfulness Based Cognitive Therapy
-
University of WarsawCompletedModerate Depressive Episode | Mild Depressive EpisodePoland
-
Fundació Sant Joan de DéuCarlos III Health InstituteNot yet recruitingMajor Depressive Disorder, Recurrent, in RemissionSpain
-
Oregon Health and Science UniversityTerminatedPostpartum Depression | Prenatal Stress | Maternal Psychological DistressUnited States
-
The University of QueenslandUniversity of Alabama at Birmingham; Rush University Medical Center; University...Completed
-
Oregon Health and Science UniversityCompletedPregnancy Related | Infant Development | Prenatal Stress | Functional Neuroimaging | Maternal Psychological DistressUnited States
-
Massachusetts General HospitalNational Center for Advancing Translational Sciences (NCATS)CompletedChronic Pain | Early Cognitive DeclineUnited States
-
University of WashingtonNational Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Chung Shan Medical UniversityCompleted
-
Massachusetts General HospitalMayo Clinic; University of Pennsylvania; University of South Florida; University... and other collaboratorsCompleted
-
University Medical Center GroningenUniversity of GroningenCompleted